NCT02719717

Brief Summary

This research program consists of a prospective, multi-institutional Phase 2 trial and an economic cost-effectiveness analysis for the use of ACE+7 in VATS lobectomy/segmentectomy compared to traditional techniques. It will be left up to the study credentialed surgeon investigator to decide the suitability of PA branches for sealing. This will be decided intra-operatively based on anatomy, vascular dissection and length as well as patient specific factors.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
150

participants targeted

Target at P50-P75 for not_applicable lung-cancer

Timeline
Completed

Started Jun 2016

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

January 28, 2016

Completed
2 months until next milestone

First Posted

Study publicly available on registry

March 25, 2016

Completed
2 months until next milestone

Study Start

First participant enrolled

June 1, 2016

Completed
2.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 9, 2018

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

November 9, 2018

Completed
Last Updated

January 27, 2020

Status Verified

March 1, 2018

Enrollment Period

2.4 years

First QC Date

January 28, 2016

Last Update Submit

January 22, 2020

Conditions

Keywords

VATS lobectomyvascular sealingenergypulmonary artery

Outcome Measures

Primary Outcomes (1)

  • For technical success absence of intra-operative bleeding directly related to PA branch ACE+7 sealing on vessels ≤7mm.

    All procedures will be video-recorded for intra-operative assessment of vascular manipulation, vessel sealing and bleeding episodes using high definition thoracoscope video recorder.

    Immediate, intra-operative evaluation

Secondary Outcomes (7)

  • Number of intra-operative transfusions

    Immediate, intra-operative

  • Number of post-operative transfusions

    After the surgery up to 30 days

  • Number of conversion to open surgery

    Immediate, intra-operative

  • Number of intra-operative mortality

    Immediate, intra-operative

  • Length of stay (days)

    After the surgery up to 30 days

  • +2 more secondary outcomes

Other Outcomes (1)

  • Number of morbidity and mortality

    From time of discharge to follow up 30 days

Study Arms (1)

Harmonic Ace+7

EXPERIMENTAL

Pulmonary artery sealing with Harmonic Ace+7 in VATS lobectomy

Device: Harmonic Ace+7

Interventions

Pulmonary artery sealing with Harmonic Ace+7 in VATS lobectomy

Harmonic Ace+7

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • ability to consent
  • \> 18 years old
  • non-hilar tumors
  • pre-operative imaging (chest CT and PET-CT
  • invasive mediastinal staging requirement will be based on current American College of Chest Physicians (ACCP) lung cancer staging criteria and will be performed by any of the following tests, in appropriate patients, alone or in combination based on study site preference in accordance with ACCP guidelines - mediastinoscopy, mediastinotomy, VATS, endobronchial ultrasound, endoscopic ultrasound.

You may not qualify if:

  • previous unilateral thoracic surgical procedure or trauma
  • history of mediastinal or pulmonary irradiation
  • anticoagulation with inability to stop anticoagulants prior to surgery
  • systemic vascular disease or vasculitis
  • uncorrectable coagulopathy

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Centre Hospitalier de l'Université de Montréal

Monteal, Quebec, H2L 4M1, Canada

Location

Related Publications (4)

  • Liberman M, Khereba M, Goudie E, Kazakov J, Thiffault V, Lafontaine E, Ferraro P. Pilot study of pulmonary arterial branch sealing using energy devices in an ex vivo model. J Thorac Cardiovasc Surg. 2014 Dec;148(6):3219-23. doi: 10.1016/j.jtcvs.2014.05.089. Epub 2014 Jul 19.

    PMID: 25125207BACKGROUND
  • Goudie E, Khereba M, Tahiri M, Hegde P, Thiffault V, Hadjeres R, Berdugo J, Ferraro P, Liberman M. Pulmonary Artery Sealing With an Ultrasonic Energy Device in Video-Assisted Thoracoscopic Surgery Lobectomy: An Animal Survival Study. Ann Thorac Surg. 2016 Oct;102(4):1088-94. doi: 10.1016/j.athoracsur.2016.04.050. Epub 2016 Jun 24.

    PMID: 27345091BACKGROUND
  • Liberman M, Khereba M, Nasir B, Goudie E, Danino A, Giot JP, Nizard N, Hadjeres R, Thiffault V, Farrenq N, Ferraro P. Pulmonary Artery Sealing Using the HARMONIC ACE+ Shears for Video-Assisted Thoracoscopic Surgery Lobectomy. Ann Thorac Surg. 2015 Sep;100(3):898-903; discussion 903-4. doi: 10.1016/j.athoracsur.2015.04.063. Epub 2015 Jul 21.

  • Liberman M, Goudie E, Morse C, Hanna W, Evans N, Yasufuku K, Sampalis J; VATS PA Study Working Group. Prospective, multicenter, international phase 2 trial evaluating ultrasonic energy for pulmonary artery branch sealing in video-assisted thoracoscopic surgery lobectomy. J Thorac Cardiovasc Surg. 2020 Jan;159(1):301-311. doi: 10.1016/j.jtcvs.2019.09.061. Epub 2019 Sep 30.

MeSH Terms

Conditions

Lung Neoplasms

Condition Hierarchy (Ancestors)

Respiratory Tract NeoplasmsThoracic NeoplasmsNeoplasms by SiteNeoplasmsLung DiseasesRespiratory Tract Diseases

Study Officials

  • Moishe Liberman, MD, PhD

    Centre hospitalier de l'Université de Montréal (CHUM)

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

January 28, 2016

First Posted

March 25, 2016

Study Start

June 1, 2016

Primary Completion

November 9, 2018

Study Completion

November 9, 2018

Last Updated

January 27, 2020

Record last verified: 2018-03

Data Sharing

IPD Sharing
Will share

Locations